VOYA Investment Management
IMDX

VOYA Investment Management’s Insight Molecular Diagnostics IMDX Stock Holding History

VOYA Investment Management’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,395
Closed -$42K – 2853
2022
Q1 		$42K Buy
1,395
+394
+39% +$12.6K ﹤0.01% 2610
2021
Q4 		$43K Sell
1,001
-334
-25% -$19.2K ﹤0.01% 2754
2021
Q3 		$95K Sell
1,335
-177
-12% -$16.3K ﹤0.01% 2746
2021
Q2 		$174K Hold
1,512
– – ﹤0.01% 2644
2021
Q1 		$157K Sell
1,512
-1
-0.1% -$95 ﹤0.01% 2597
2020
Q4 		$72K Buy
1,513
+501
+50% +$18.4K ﹤0.01% 2620
2020
Q3 		$28K Buy
1,012
+243
+32% +$6.97K ﹤0.01% 2485
2020
Q2 		$29K Buy
+769
New +$39.7K ﹤0.01% 2491

Other funds holding IMDX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

VOYA Investment Management's IMDX Position: Q2 2022 in Review

VOYA Investment Management sold out of Insight Molecular Diagnostics (IMDX) in Q2 2022, closing a stake of 1,395 shares — an estimated $42K sold.

VOYA Investment Management first reported a position in IMDX in Q2 2020 and held it in 8 quarters. The position peaked at $174K in Q2 2021. 75 funds tracked by Wall St. Rank hold IMDX as of Q2 2022.

  • VOYA Investment Management reported no remaining Insight Molecular Diagnostics position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 1,395 Insight Molecular Diagnostics shares in Q2 2022, an estimated $42K.
  • VOYA Investment Management first reported a position in Insight Molecular Diagnostics in Q2 2020 and held it in 8 quarters.
  • VOYA Investment Management's Insight Molecular Diagnostics position peaked at $174K in Q2 2021.
  • 75 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.